Influence of seasonal exposure to grass pollen on local and peripheral blood IgE repertoires in patients with allergic rhinitis by Wu, Yu-Chang B. et al.
Rhinitis, sinusitis, and upper airway disease
Influence of seasonal exposure to grass pollen on local and
peripheral blood IgE repertoires in patients with allergic
rhinitis
Yu-Chang B. Wu, PhD,a,b Louisa K. James, PhD,a,b Jason A. Vander Heiden, MSc,c Mohamed Uduman, PhD,d
Stephen R. Durham, MD, FRCP,b,e Steven H. Kleinstein, PhD,c,d David Kipling, DPhil,f and Hannah J. Gould, PhDa,b
London and Cardiff, United Kingdom, and New Haven, ConnBackground: Previous studies of immunoglobulin gene
sequences in patients with allergic diseases using
low-throughput Sanger sequencing have limited the analytic
depth for characterization of IgE repertoires.
Objectives: We used a high-throughput, next-generation
sequencing approach to characterize immunoglobulin
heavy-chain gene (IGH) repertoires in patients with seasonal
allergic rhinitis (AR) with the aim of better understanding the
underlying disease mechanisms.
Methods: IGH sequences in matched peripheral blood and
nasal biopsy specimens from nonallergic healthy control
subjects (n 5 3) and patients with grass pollen–related AR
taken in season (n 5 3) or out of season (n 5 4) were amplified
and pyrosequenced on the 454 GS FLX1 System.
Results: A total of 97,610 IGH (including 8,135 IgE) sequences
were analyzed. Use of immunoglobulin heavy-chain variable
region gene families 1 (IGHV1) and 5 (IGHV5) was higher in
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604independent of atopic status. IgE repertoires measured inside
the grass pollen season were more diverse and more mutated
(particularly in the biopsy specimens) and had more evidence of
antigen-driven selection compared with those taken outside of
the pollen season or from healthy control subjects. Clonal
relatedness was observed for IgE between the blood and nasal
biopsy specimens. Furthermore in patients with AR, but not
healthy control subjects, we found clonal relatedness between
IgE and IgG classes.
Conclusion: This is the first report that exploits next-generation
sequencing to determine local and peripheral blood IGH
repertoires in patients with respiratory allergic disease. We
demonstrate that natural pollen exposure was associated with
changes in IgE repertoires that were suggestive of ongoing
germinal center reactions. Furthermore, these changes were
more often apparent in nasal biopsy specimens compared
with peripheral blood and in patients with AR compared
with healthy control subjects. (J Allergy Clin Immunol
2014;134:604-12.)
Key words: Next-generation sequencing, peripheral blood and
nasal mucosal IgE repertoires, allergic rhinitis
The immunoglobulin repertoire in the periphery is shaped
by somatic hypermutation (SHM), class-switch recombination
(CSR), and affinity maturation within the germinal centers
(GCs) of lymphoid tissues in response to antigens. The pivotal
role of IgE in allergic inflammation is well characterized,1
particularly as highlighted by the clinical efficacy of anti-IgE
therapy.2 Recently, several mouse models have been developed
in an attempt to unravel the mystery of IgE1 B-cell
ontogeny3; however, mechanisms behind the prevalence of
IgE1 B cells in human subjects remain unclear. Although
Sanger sequencing has been applied to study IgE repertoires
in patients with allergic disease,4,5 its low sequence yield
and limited coverage has resulted in conflicted findings, such
as the role of classical T cell–dependent antigens versus super-
antigens in shaping the selected IgE repertoire in patients with
allergic disease.6-12
Over recent years, sequencing technologies have evolved
dramatically, advancing from the low-throughput Sanger-based
methods to massively parallel and high-throughput approaches
that are enabled by several next-generation sequencing (NGS)
platforms.13 In 2009, Weinstein et al14 published the first NGS
study on zebrafish immunoglobulin repertoires, and just
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monitoring immunoglobulin repertoires in clinical specimens.
Since then, NGS technologies have been applied to various
studies of B-cell development,16-20 vaccination responses,21,22
cancer,23 and both infectious24,25 and autoimmune diseases.26
The unprecedentedly large numbers of immunoglobulin se-
quences generated by using NGS technologies have revolution-
ized our ability to determine the abundance, relatedness
selection, and SHM of B-cell clones, thus providing a wealth of
information relevant to the generation of immune memory and
antibody responses in both health and disease. Applications of
NGS technologies have expanded beyond basic immunology
research into drug discovery27,28 and clinical diagnostics.15,29 In
combination with mAb expression and structural biology, NGS
technologies have led to the discovery of broadly neutralizing an-
tibodies against HIV-1.25,28 The potential value of NGS for clin-
ical biomarker discovery has also been explored.21,23,30 Despite
this, NGS technologies have not yet been applied to the study
of IgE repertoires in patients with respiratory allergic disease.
Seasonal allergic rhinitis (AR) affects a quarter of the popu-
lation of westernized countries, and a large proportion of these
patients are allergic to pollens. In this report a high-throughput
NGS approach is introduced to characterize immunoglobulin
heavy-chain gene (IGH) repertories in matched peripheral blood
and nasal mucosal biopsy specimens from patients with AR inside
the grass pollen season (AR.IS group), patients with AR outside
the pollen season (AR.OS group), and nonallergic healthy control
subjects (NA group). We detected significant changes in the IgE
repertoire (as well as those of other antibody classes) in the
AR.IS group with evidence of enhanced affinity maturation for
IgE as a result of natural exposure to seasonal grass pollen.
This report demonstrated the technical feasibility and usefulness
of high-throughput NGS repertoire analysis in respiratory allergic
disease research.METHODS
Study participants
Subjects with different atopic statuses, the AR.OS group (n5 3), the AR.IS
group (n 5 4), and the NA group (n 5 3), were recruited from the Royal
Brompton Hospital London allergy clinic or through local advertisement (see
the Methods section and Table E1 in this article’s Online Repository at www.
jacionline.org). Samples were collected after obtaining written informed con-
sent, as approved by the East London & The City REC Alpha (09/H0704/67).Sample processing
Nasal biopsy specimens (2.5 mm) were taken from the inferior turbinate
after achievement of local anesthesia and subsequently homogenized with aQiagen TissueLyser (Qiagen, Hilden, Germany). Peripheral blood lympho-
cytes were isolated from venous blood by using Ficoll density gradient
separation (GEHealthcare, Fairfield, Conn). Total RNAwas extracted with the
RNeasy Mini Kit (Qiagen), and cDNAwas synthesized by using SuperScript
III RT (Invitrogen, Carlsbad, Calif).454 Pyrosequencing of IGH libraries
As previously described,21 libraries containing IGH sequences were gener-
ated by means of seminested PCR reactions (see the Methods section and
Table E2 in this article’s Online Repository at www.jacionline.org) with a
mixture of sense primers (framework region 1/immunoglobulin heavy-chain
variable region [IGHV] gene families 1-7 for respective framework 1 regions)
in conjunction with antisense primers (IGa, IGg, IGε, and IGm for IgA, IgG,
IgE, and IgM, respectively). Processed library IGH sequences were pyrose-
quenced on the 454 GS FLX1 System (Roche, Mannheim, Germany).Sequence analysis pipeline
As previously described,21 the analysis pipeline has 4 components: an
initial quality control (QC), IMGT/HighV-QUESTannotation, hierarchic clo-
notype clustering, and designation of clonotypic sequences (see the Methods
section in this article’s Online Repository). For some analyses, sequenceswere
clustered by using more stringent criteria (see the Methods section in this ar-
ticle’s Online Repository).Analysis of selection strength and clonal diversity
Selection strength for complementarity-determining regions (CDRs) and
framework regions in sampled immunoglobulin sequences was estimated by
using BASELINe (see the Methods section in this article’s Online Reposi-
tory).31 Clonal diversity was analyzed by using the model proposed by Hill
(see the Methods section in this article’s Online Repository).32Construction of lineage trees
The Phylogeny Inference Package (PHYLIP)33 was used to construct line-
age trees containing unique clonal members with sequence variations. Se-
quences were further aligned against germlines where necessary by using
the LasergeneGenomics Suite (DNAstar,Madison,Wis) for validation of their
clonal relatedness.Statistics
Depending on the nature of data sets, different statistical methods were
used for multiple group comparisons by using GraphPad Prism 6.0 software
(GraphPad Software, La Jolla, Calif; see the Methods section in this article’s
Online Repository). Metrics of association were determined by using Pearson
correlation and linear regression.RESULTS
Filtering and clonotype clustering of IGH sequences
A total of 152,784 sequence reads were generated from 20
samples. After QC analysis, 97,610 IGH sequences were identi-
fied, comprising 8,135 full-length IgE sequences (see Table E3
in this article’s Online Repository at www.jacionline.org). QC-
filtered sequences can be searched on the National Center for
Biotechnology Information’s Sequence Read Archive (Sequence
Read Archive study accession no. SRP038092, see Table E1).
Hierarchic clustering then allowed us to group clonally related se-
quences based on the third IGH CDR (CDR-H3) DNAmotifs and
identify 35,175 clonotypic sequences to represent their clonal
families (see Table E4 in this article’s Online Repository at
www.jacionline.org).
FIG 1. Abundance of IGHV genes in clonotypic repertoires by antibody class and sample type. A and B,Use
of IGHV gene families in IgE clonotypic repertoires was compared across sample types and patient groups
(Fig 1, A) or with other antibody classes (Fig 1, B). C, Use of individual IGHV genes was compared between
antibody classes. *P < .05 and **P < .005. Fig 1, B and C, Groups of clonotypic sequences were combined
from peripheral blood and biopsy specimens independent of atopic status.
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Specific antigen challenge might enrich B cells expressing
particular immunoglobulin genes, changing the landscape of
immunoglobulin repertoires.16 For example, IGHV5 genes have
been associated with antibody responses to superantigens. There-
fore we compared the relative abundance of immunoglobulin
genes to determine whether natural pollen exposure increased
particular IGH gene rearrangements. We observed that the use
of IGHV gene families (Fig 1, A), IGHD gene families (see Fig
E1, A, in this article’s Online Repository at www.jacionline.
org), and IGHJ gene families (see Fig E1, B) for IgE clonotypes
did not significantly differ between allergic and nonallergic sub-
jects. Differences between peripheral blood and biopsy speci-
mens were very minor. However, we detected increased use of
IGHV3 gene families and a trend for reduced use of IGHV4
gene families in nasal biopsy specimens from the NA and
AR.OS groups but not the AR.IS group compared with their coun-
terparts in peripheral blood.
Similar patterns of IGH gene rearrangements between IgA and
IgG repertoires allowed us to group them as one switched IgE2
(IgA and IgG) population.16,17 IgE sequences as a whole (IgE se-
quences from all 20 samples combined) showed a significant in-
crease in the use of IGHV1 and IGHV5 gene families but a
reduction for IGHV2 and IGHV3 (Fig 1, B) compared with IgM
and switched IgE2 sequences. Similar patterns were observed
separately in peripheral blood (see Fig E1, C) and nasal biopsy
specimens (see Fig E1, D). IgE repertoires were also distinct
significantly from other classes in their use of IGHD gene families
(see Fig E1, E), IGHJ gene families (see Fig E1, F), and individ-
ual IGHV genes (Fig 1, C). Approximately 11 of 58 IGHV genes,such as IGHV5-a, differed in abundance for IgE clonotypic reper-
toires compared with other classes. In addition, significant
changes between patient groups were observed in the use of
some IGHV families (IGHV1, IGHV2, and IGHV5) for IgM
(see Fig E1, G and H) and switched IgE2 (see Fig E1, I and J)
repertoires.IGHV mutation status
Increased mutation numbers in the IGHV region are indicative
of higher-affinity antigen binding.34 Therefore the frequency of
IGHVmutations was determined as the number of nucleotide dif-
ferences compared with germline sequence per 10,000 bases. IgE
and switched IgE2 sequences had significantly more mutations
than IgM sequences (Fig 2, A and B). Within the IgE class, there
were more mutations in the AR group (Fig 2, C and D), with
further increases observed in biopsy specimens taken in season
(Fig 2, E and F). Regardless of antibody class, the mutation fre-
quency was increased (Fig 2, D, F, and G), and the proportion
of germline-like (<_ 200 mutations per 10,000 bases) sequences
was significantly reduced in biopsy specimens taken in season
(see Fig E2, A and B, in this article’s Online Repository at
www.jacionline.org). In contrast, the opposite pattern for IgM
and switched IgE2 sequences was observed in peripheral blood.
We further analyzed the degree of sequence variations among
related mutants within each IgE clonal family as a way of
assessing intraclonal diversification as a cause of clonal expan-
sion and SHM. Thus intraclonal variation was calculated as the
SD of IGHVmutations among all clonally related sequences. IgE
clones taken in season had the highest degree of intraclonal
variations for larger clones (clone size >3 sequences per clone;
FIG 2. Changes in IGHV mutation levels by antibody class and sample type. A and B, Mean mutation fre-
quencies were compared between clonotypic sequences of different antibody classes in peripheral blood
(Fig 2, A) and nasal biopsy specimens (Fig 2, B). IgA and IgG repertories were combined as one switched
IgE2 population. C-F, Mean mutation levels in IgE sequences were further compared between the NA
and AR groups (Fig 2, C and D) or between groups of sequences taken in and out of season (Fig 2, E and
F). Red line, Two percent background error rate. G, Pie charts show relative fractions of IgE clonotypes
ranked by mutations in peripheral blood and nasal biopsy specimens from the NA group (inner circles),
AR.OS group (middle circles), and AR.IS group (outer circles). GL, Germline like, <_200 mutations per
10,000 bases; Mutated, >200 mutations per 10,000 bases. ****P < .00005. ns, Not significant.
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FIG 3. Patterns of CDR-H3 length. A, Virtual CDR-H3 spectratypes show the relative distribution of clono-
typic sequences by CDR-H3 length for unmutated IgM (gray bars) and IgEAR (red bars; AR.IS and AR.OS
groups combined). a.a, Amino acids. B,Mean CDR-H3 length was compared between groups, as indicated.
C, Nucleotide numbers for different CDR-H3 components in IgE sequences were compared between the
IgENA and IgEAR groups (AR.IS and AR.OS groups combined). D,Mean CDR-H3 length for IgE clonotypic se-
quences was compared between groups in peripheral blood (PB) and nasal biopsy specimens (NB). *P < .05,
**P < .005, and ****P < .00005. ns, Not significant.
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out of season (see Fig E2, D).Physicochemical properties of CDR-H3
CDR-H3 is regarded as the most important motif within
immunoglobulin genes because of its central position in the
antigen-binding pocket. Therefore we analyzed the physiochem-
ical properties of CDR-H3 peptides. CDR-H3 motifs of unmu-
tated (100% germline) IgM sequences were extracted from the
whole data set to represent the most diverse fraction for compar-
ison. Among antibody classes, CDR-H3 was longest in length for
IgM but shortest for IgE (Fig 3, A and B). IgE sequences from
allergic subjects (in and out of season combined) had significantly
longer CDR-H3 (60% < 15 nucleotides; see Fig E3, A, in this ar-
ticle’s Online Repository at www.jacionline.org) than the NA
group (80% <15 nucleotides). This was mainly due to increased
N-nucleotide numbers and IGHD lengths in allergic subjects
(Fig 3,C). This pattern remained evident for IgE isolated from pe-
ripheral blood, as well as IgE from biopsy specimens (Fig 3, D).
Although the CDR-H3 length for IgE did not differ in allergic sub-
jects between samples taken in or out of season (data not shown),
we observed different patterns in IgM and switched IgE2 reper-
toires between different atopic status (see Fig E3, B and C).
The number of IGHV mutations within an immunoglobulin
sequence often negatively correlates with its CDR-H3 length.35,36
In keeping with this, we observed a negative correlation between
CDR-H3 lengths and IGHVmutations for IgE from the NA group
(see Fig E4, A, in this article’s Online Repository at www.
jacionline.org) and AR.OS group (see Fig E4, B) samples.However, this correlation was not observed in the AR.IS group
(Fig E4, C). In addition, we did not detect any significant differ-
ences of CDR-H3 peptide properties, including the aliphatic in-
dex, grand average of hydropathicity index, and theoretic
isoelectric point (see Fig E5 in this article’s Online Repository
at www.jacionline.org), when comparing IgE sequences between
the patient groups.Analysis of selection strength and clonal diversity
B-cell selection is a pivotal process for affinity maturation of
antibodies in which positive selection can often improve antibody
affinity and negative selection can contribute to the structural
integrity of antibodies.31 Therefore we used BASELINe to esti-
mate selection strength imposed on the IGH repertoires. When
comparing IgE sequences between the AR.IS and AR.OS groups,
we observed distinctive patterns of selection (Fig 4). For IgE se-
quences from the AR.IS group, we found evidence of stronger
negative selection in peripheral blood (Fig 4, A); however, nasal
biopsy specimens showed stronger positive selection (Fig 4, B)
compared with other atopic statuses.
The repertoire diversity of B cells is influenced by selection
strength, and a repertoire with a higher degree of diversity is more
likely to recognize a wider array of antigens (ie, a less focused
immune response) than a more restricted repertoire. To quantify
diversity (0D) within each population of clones, we used the
generalized diversity model proposed by Hill (see the Methods
section and Fig E6 in this article’s Online Repository at www.
jacionline.org).32 IgE clones were the least diverse compared
with other antibody classes (Fig 5, A and B).32 Within the IgE
FIG 4. Selection strength of IgE sequences. Mean selection strength (S) for CDRs and framework regions
(FWRs) for IgE clones in peripheral blood (A) or nasal biopsy specimens (B)were compared between atopic
statuses. Values indicate means 6 95% CIs. *P < .05, **P < .005, and ****P < .00005.
FIG 5. Analysis of clonal diversity using Hill’s model.32 The diversity of total
clones (0D) was compared across antibody classes in peripheral blood (A)
and nasal biopsy specimens (B) or between IgE clones from different pa-
tient groups in peripheral blood (C) and nasal biopsy specimens (D). Values
indicate means 6 95% CIs. *P < .05 and **P < .005.
TABLE I. Lineage tree frequency with clonal relatedness
between IgE and other classes
IgE related to: NA group
AR.IS and
AR.OS groups
IgM 3* (0.29%) 2 (0.31%)
IgA and IgM 1 (0.10%) 0
IgA 2 (0.19%) 2 (0.31%)
IgG 0 1 (0.15%)
IgG and IgM 0 1 (0.15%)
*Absolute number observed.
Frequency is calculated based on clone counts in Table E3.
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least diverse (Fig 5, C), whereas IgE clones from nasal biopsy
specimens taken in season had the highest measure of diversity
(Fig 5, D).IgE lineage trees and clonal relatedness
Lineage tree analysis was used to identify sequences across
different antibody classes, sample types, or both. By clustering
clonally related sequences and analyzing their mutation patterns,
we were able to generate 1,752 lineage trees (data not shown). Of
these, IgE sequences were present in 146 lineage trees (see Table
E5). Trees containing only IgE sequences (eg, GL35882; Fig 6) or
IgE and their variants of other antibody classes (eg, GL12091)
were detected in nasal biopsy specimens. Twenty-one trees
were associated with IgE sequences in peripheral blood to their
IgE relatives in nasal biopsy specimens without a clearly defined
lineage order (eg, GL32184, GL21643, and GL41187). Twelve
lineage trees displayed molecular footprints that linked IgE to
other classes (see Table E6). The relative frequencies of trees con-
taining IgE sequences related to IgM (eg, GL12091 and
GL25649) or IgE sequences related to IgA (eg, GL18412 and
GL22489) did not significantly differ between allergic subjects
and nonallergic subjects (Table I). In contrast, we found clonal
relatedness between IgE and IgG classes in 2 of 650 trees from
AR samples (GL5221 and GL23596; 0.31%; P 5 .05, x2 test)
but none in the 1,094 trees from nonallergic samples.DISCUSSION
Previous studies of the human IgE repertoire were restricted by
the use of low-throughput Sanger sequencing. To the best of our
knowledge, the largest number of IgE sequences analyzed in a
single report was limited to 1,366 IgE sequences isolated from the
blood of 13 asthmatic children.9 Here we applied a high-
throughput NGS approach and captured 8,135 IgE sequences
(525 IgE clonotypes) from the peripheral blood and nasal mucosa
of 9 adults. The small number of subjects reported heremeans that
we are unable to draw general conclusions regarding the develop-
ment of IgE repertoires in allergic disease. This would require a
much larger cohort of patients or multiple types of studies with
different patient groups to account for interindividual variations
that naturally arise from differing conditions of sensitization
and many clinical phenotypes (including disease severity and
polymorphisms within the immunoglobulin gene locus). Despite
these limitations, we have demonstrated the value of NGS reper-
toire analysis in allergy research and have been able to assess the
influence of natural pollen exposure on the IGH repertoire in a
small cohort of patients with AR.
Antigen stimulation often leads to selection for or against
particular IGH gene rearrangements, resulting in altered
FIG 6. Examples of lineage trees containing IgE sequences. Only representative trees are presented for
illustration purposes. Sequences from peripheral blood or nasal biopsy specimens are indicated by colored
circles, with the number of pointmutations between 2 adjacent sequences shown next to each branch (point
mutation 5 1 when not indicated). Antibody classes (A, IgA; G, IgG; E, IgE;M, IgM) and subclasses (G1-G4,
IgG; A1 and A2, IgA) are indicated within the circles. Only unique sequences with identifiable antibody clas-
ses are shown. Detailed information for the 12 trees containing IgE sequences and their related variants of
other classes are shown in Table E6.
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this report we observed a more limited diversity for IgE clones
compared with other antibody classes, indicating that IgE clones
might be more stringently selected. Furthermore, in contrast to a
previous report describing similar use of IGHV between IgM and
IgE repertoires,9 the IgE clonotypic repertoires reported here had
characteristically higher use of IGHV1 and IGHV5 gene families
but lower IGHV3 use independent of atopic status compared with
IgM. Although our sequence data alone cannot determine the na-
ture of antigen stimulation, the distinct repertoire profile of IgE
clonotypes suggests that IgE1 B cells might be subject to selec-
tion pressures different from other antibody classes. The over-
abundance of the minor IGHV5 subgroup in the IgE repertoire
has been suggested to associate with the pathogenesis of allergic
disease,6,8,12 as previously demonstrated by comparing IgE and
IgM repertoires within allergic subjects.6,7 However, our results
suggest that the overabundance of IGHV5 might be specific to
IgE but not to allergy per se. Further studies are required to
confirm this finding and exclude any confounding variables
related to disease status or sampling efficiency.
Recent data from a mouse model suggest that high-affinity IgE
antibodies might arise through high-affinity, hypermutated IgG
intermediates that undergo sequential CSR to IgE.37 Althoughprevious studies showed that IgE transcripts in patients with AR
and asthma are heavily mutated,9,10 the effect of allergen expo-
sure on GC reactions has not hitherto been directly demonstrated.
Here we have shown that IgE sequences were highly mutated,
regardless of atopic status. Crucially, our results demonstrated
that IgE sequences from patients with AR were even more
mutated and more varied during the pollen season. One potential
explanation for these observations is that hypermutation is accu-
mulated at a faster rate for IgE1 B cells in allergic patients under
the influence of allergen exposure. Alternatively, increased muta-
tions for IgE transcripts in season could be associated with
enhanced sequential CSR from IgG to IgE, as previously reported
in asthmatic patients.38 To test this, we performed a lineage tree
analysis, which was mainly used to determine clonal relatedness
across antibody classes but not to delineate the exact develop-
mental progression in vivo, given the unlikeliness of capturing
all clonal members at the time of sampling. For example, it would
be biologically implausible for IgG2/4 to switch to IgG1/3, as illus-
trated in our own lineage trees.39 In such cases the hierarchic re-
lationships suggest the existence of a common precursor rather
than direct descent. With this caveat, the clonal relatedness we
observed between IgE and IgG in samples from allergic patients,
in contrast to its absence in healthy control subjects, suggests that
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allergic disease. This prediction is amenable to further investiga-
tion with a larger cohort of patients. Nevertheless, it is supported
by the increased frequency of I 3-Cg switch circle transcripts (tran-
sient markers of CSR from IgG to IgE) in the bronchial mucosa of
asthmatic patients compared with healthy control subjects.38
Hypermutation patterns have detrimental effects on the selec-
tion of B cells and, subsequently, the diversity and affinity of
antibodies. A previous study showed evidence of negative selec-
tion in framework regions but did not observe any specific
patterns for CDRs in IgE sequences.40 By using BASELINe to
quantify selection strength, we detected significant evidence of
antigen-driven selection for IgE transcripts, particularly in pe-
ripheral blood. Furthermore, our data demonstrate a unique selec-
tive environment that operates among patients with AR in season
and differing pressures between peripheral blood and nasal
mucosal compartments. Specifically, we observed that although
IgE clones in peripheral blood taken in season were more nega-
tively selected and subsequently had reduced clonal diversity,
IgE clones in nasal mucosae taken in season were more positively
selected, contributing to an increase in their clonal diversity.
It remains unclear exactly where, if at all, IgE1B cells undergo
affinity maturation. Increasing evidence suggests that GC-like
structures containing IgE1 B cells are present in both the upper
and lower airways in patients with AR and allergic asthma,
respectively.38,41,42 Here we observed evidence of clonal expan-
sion and increases in IGHVmutations and diversity of IgE clones
isolated from the nasal mucosa. These observations were consis-
tent with stronger positive selection that we observed in mucosal
IgE in patients with AR in season. In part, these results might
reflect selection of IgG clones and formation of IgG1 memory
cells in the primary sensitization to allergens localized in the
target organ, followed by allergen stimulation of clonal expan-
sions and CSR to IgE. Using lineage tree analysis, we also found
molecular footprints that linked IgE to other antibody classes in
the nasal biopsy specimens, supporting this hypothesis. Alto-
gether, our observations point to the possibility that the allergic
respiratory mucosa supports local affinity maturation of IgE,
which is consistent with the detection of activation-induced cyti-
dine deaminase and switch circle transcripts in the target organ in
patients with AR and asthma, as well as nasal polyposis.38,42,43
However, it is entirely possible that some IgE transcripts detected
in nasal biopsy specimens could represent plasma cells that have
undergone GC reactions in regional lymph nodes before
migrating to the nasal mucosa.44 Further studies on cell traf-
ficking in the human system will help to address both
possibilities.
There are important questions that remain to be answered.
First, as previously reported for atopic dermatitis,11 we observed a
fraction of germline-like IgE transcripts in all groups independent
of atopic status. Presumably, this germline-like IgE1 population
is derived through direct CSR from IgM to IgE and has been sug-
gested to arise through polyclonal activation of B1-like CD51 B
cells.11 Because the relative proportion of germline-like versus
mutated IgE1 populations was different between allergic and
healthy subjects, directly characterizing these IgE1 populations
both phenotypically and functionally might help us better under-
stand their differing roles in allergic responses.
Second, we observed that IgE sequences taken in season from
patients with AR were more mutated but had longer CDR-H3.
Increased hypermutation and shorter CDR-H3 are suggestive ofspecific antigen-driven responses, whereas polyreactivity has
been associated with longer CDR-H3.35,36 The true relevance of
the increased CDR-H3 lengths we have observed in IgE se-
quences from allergic patients remains to be determined, which
will require generation of recombinant antibodies for functional
analysis.11,45
Third, whether the alterations observed in non-IgE repertoires
are relevant to the development of IgE1 B cells and the nature of
allergic response in patients with AR remains to be investigated in
future studies.
In conclusion, we observe that the pattern of IGH gene rear-
rangements in the IgE repertoire was similar for all groups but
distinct from other antibody classes independent of atopic sta-
tus. Our data demonstrate seasonal and compartmental differ-
ences in clonal diversity and selection strength of IgE and
provide direct evidence of increased hypermutation for IgE1
cells in patients with AR under the influence of natural pollen
exposure. Our lineage tree analysis reveals intraclonal diversifi-
cation of IgE clones and association of IgE repertoires between
the blood and nasal mucosal compartments. Finally, clones
shared between IgE and IgG classes are detected in allergic sub-
jects but absent in nonallergic subjects, which is indicative of
preferential sequential switching through IgG in allergic sub-
jects. Taken together, these data demonstrate NGS as a powerful
approach to study the immune repertoire in patients with allergic
diseases.
We thank all of the volunteers who provided nasal biopsy specimens and
blood for this study. We also thank Andrea Goldstone (Royal Brompton
Hospital London, United Kingdom) recruiting volunteers, providing clinical
data, and collecting samples.
Key messages
d Natural exposure to grass pollen is associated with
enhanced SHM, increased diversity, and changes in selec-
tion and CSR patterns for IgE repertoires in patients with
AR.
d IgE repertoires linking peripheral blood and nasal
mucosal compartments have a distinct pattern of IGH
rearrangements independent of atopic status.
d We demonstrate the technical feasibility and analytic po-
wer of NGS for the determination of immunoglobulin rep-
ertoires in patients with respiratory allergic disease.
REFERENCES
1. Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol 2008;8:
205-17.
2. Holgate ST, Chuchalin AG, Hebert J, Lotvall J, Persson GB, Chung KF, et al. Ef-
ficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab)
in severe allergic asthma. Clin Exp Allergy 2004;34:632-8.
3. Davies JM, Platts-Mills TA, Aalberse RC. The enigma of IgE1 B-cell memory in
human subjects. J Allergy Clin Immunol 2013;131:972-6.
4. Lim A, Luderschmidt S, Weidinger A, Schnopp C, Ring J, Hein R, et al. The IgE
repertoire in PBMCs of atopic patients is characterized by individual rearrange-
ments without variable region of the heavy immunoglobulin chain bias.
J Allergy Clin Immunology 2007;120:696-706.
5. Eibensteiner P, Spitzauer S, Steinberger P, Kraft D, Valenta R. Immunoglobulin E
antibodies of atopic individuals exhibit a broad usage of VH-gene families. Immu-
nology 2000;101:112-9.
6. Snow RE, Chapman CJ, Frew AJ, Holgate ST, Stevenson FK. Pattern of usage and
somatic hypermutation in the V(H)5 gene segments of a patient with asthma: im-
plications for IgE. Eur J Immunol 1997;27:162-70.
J ALLERGY CLIN IMMUNOL
SEPTEMBER 2014
612 WU ET AL7. Snow RE, Djukanovic R, Stevenson FK. Analysis of immunoglobulin E VH tran-
scripts in a bronchial biopsy of an asthmatic patient confirms bias towards VH5,
and indicates local clonal expansion, somatic mutation and isotype switch events.
Immunology 1999;98:646-51.
8. Coker HA, Harries HE, Banfield GK, Carr VA, Durham SR, Chevretton E, et al.
Biased use of VH5 IgE-positive B cells in the nasal mucosa in allergic rhinitis.
J Allergy Clin Immunol 2005;116:445-52.
9. Kerzel S, Rogosch T, Struecker B, Maier RF, Zemlin M. IgE transcripts in the cir-
culation of allergic children reflect a classical antigen-driven B cell response and
not a superantigen-like activation. J Immunol 2010;185:2253-60.
10. Davies JM, O’Hehir RE. VH gene usage in immunoglobulin E responses of sea-
sonal rhinitis patients allergic to grass pollen is oligoclonal and antigen driven.
Clin Exp Allergy 2004;34:429-36.
11. Edwards MR, Brouwer W, Choi CH, Ruhno J, Ward RL, Collins AM. Analysis of
IgE antibodies from a patient with atopic dermatitis: biased V gene usage and ev-
idence for polyreactive IgE heavy chain complementarity-determining region 3.
J Immunol 2002;168:6305-13.
12. van der Stoep N, van der Linden J, Logtenberg T. Molecular evolution of the hu-
man immunoglobulin E response: high incidence of shared mutations and clonal
relatedness among epsilon VH5 transcripts from three unrelated patients with
atopic dermatitis. J Exp Med 1993;177:99-107.
13. Georgiou G, Ippolito GC, Beausang J, Busse CE, Wardemann H, Quake SR. The
promise and challenge of high-throughput sequencing of the antibody repertoire.
Nat Biotechnol 2014;32:158-68.
14. Weinstein JA, Jiang N, White RA 3rd, Fisher DS, Quake SR. High-throughput
sequencing of the zebrafish antibody repertoire. Science 2009;324:807-10.
15. Boyd SD, Marshall EL, Merker JD, Maniar JM, Zhang LN, Sahaf B, et al. Mea-
surement and clinical monitoring of human lymphocyte clonality by massively par-
allel VDJ pyrosequencing. Sci Transl Med 2009;1:12ra23.
16. Wu YC, Kipling D, Leong HS, Martin V, Ademokun AA, Dunn-Walters DK.
High-throughput immunoglobulin repertoire analysis distinguishes between hu-
man IgM memory and switched memory B-cell populations. Blood 2010;116:
1070-8.
17. Wu Y-CB, Kipling D, Dunn-Walters DK. The relationship between CD27
negative and positive B cell populations in human peripheral blood. Front Immunol
2011;2:81.
18. Larimore K, McCormick MW, Robins HS, Greenberg PD. Shaping of human
germline IgH repertoires revealed by deep sequencing. J Immunol 2012;189:
3221-30.
19. Briney BS, Willis JR, McKinney BA, Crowe JE Jr. High-throughput antibody
sequencing reveals genetic evidence of global regulation of the naive and memory
repertoires that extends across individuals. Genes Immun 2012;13:469-73.
20. Mroczek ES, Ippolito GC, Rogosch T, Hoi KH, Hwangpo TA, Brand MG, et al.
Differences in the composition of the human antibody repertoire by B cell subsets
in the blood. Front Immunol 2014;5:96.
21. Ademokun A, Wu YC, Martin V, Mitra R, Sack U, Baxendale H, et al. Vaccination-
induced changes in human B-cell repertoire and pneumococcal IgM and IgA anti-
body at different ages. Aging Cell 2011;10:922-30.
22. Lavinder JJ, Wine Y, Giesecke C, Ippolito GC, Horton AP, Lungu OI, et al. Iden-
tification and characterization of the constituent human serum antibodies elicited
by vaccination. Proc Natl Acad Sci U S A 2014;111:2259-64.
23. He J, Wu J, Jiao Y, Wagner-Johnston N, Ambinder RF, Diaz LA Jr, et al. IgH gene
rearrangements as plasma biomarkers in Non- Hodgkin’s lymphoma patients. On-
cotarget 2011;2:178-85.
24. Jiang N, He J, Weinstein JA, Penland L, Sasaki S, He XS, et al. Lineage structure
of the human antibody repertoire in response to influenza vaccination. Sci Transl
Med 2013;5:171ra19.
25. Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, Wang C, et al. Focused evolution of
HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science
2011;333:1593-602.26. von Budingen HC, Kuo TC, Sirota M, van Belle CJ, Apeltsin L, Glanville J, et al. B
cell exchange across the blood-brain barrier in multiple sclerosis. J Clin Invest
2012;122:4533-43.
27. Ravn U, Didelot G, Venet S, Ng KT, Gueneau F, Rousseau F, et al. Deep
sequencing of phage display libraries to support antibody discovery. Methods
2013;60:99-110.
28. Zhu J, Ofek G, Yang Y, Zhang B, Louder MK, Lu G, et al. Mining the antibo-
dyome for HIV-1-neutralizing antibodies with next-generation sequencing and
phylogenetic pairing of heavy/light chains. Proc Natl Acad Sci U S A 2013;
110:6470-5.
29. Gawad C, Pepin F, Carlton VE, Klinger M, Logan AC, Miklos DB, et al. Massive
evolution of the immunoglobulin heavy chain locus in children with B precursor
acute lymphoblastic leukemia. Blood 2012;120:4407-17.
30. Parameswaran P, Liu Y, Roskin KM, Jackson KK, Dixit VP, Lee JY, et al.
Convergent antibody signatures in human dengue. Cell Host Microbe 2013;13:
691-700.
31. Yaari G, Uduman M, Kleinstein SH. Quantifying selection in high-throughput
Immunoglobulin sequencing data sets. Nucleic Acids Res 2012;40:e134.
32. Hill MO. Diversity and evenness: a unifying notation and its consequences. Ecol-
ogy 1973;54:427-32.
33. Felsenstein J. PHYLIP—phylogeny inference package (version 3.2). Cladistics
1989;5:164-6.
34. Yang PL, Schultz PG. Mutational analysis of the affinity maturation of antibody
48G7. J Mol Biol 1999;294:1191-201.
35. Crouzier R, Martin T, Pasquali JL. Heavy chain variable region, light chain variable
region, and heavy chain CDR3 influences on the mono- and polyreactivity and on
the affinity of human monoclonal rheumatoid factors. J Immunol 1995;154:
4526-35.
36. Volpe JM, Kepler TB. Large-scale analysis of human heavy chain V(D)J recombi-
nation patterns. Immunome Res 2008;4:3.
37. Xiong H, Dolpady J, Wabl M, Curotto de Lafaille MA, Lafaille JJ. Sequential class
switching is required for the generation of high affinity IgE antibodies. J Exp Med
2012;209:353-64.
38. Takhar P, Corrigan CJ, Smurthwaite L, O’Connor BJ, Durham SR, Lee TH, et al.
Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic
patients with asthma. J Allergy Clin Immunol 2007;119:213-8.
39. Niederberger V, Niggemann B, Kraft D, Spitzauer S, Valenta R. Evolution of IgM,
IgE and IgG(1-4 )antibody responses in early childhood monitored with recombi-
nant allergen components: implications for class switch mechanisms. Eur J Immu-
nol 2002;32:576-84.
40. Levin M, Ohlin M. Inconclusive evidence for or against positive antigen selection
in the shaping of human immunoglobulin E repertoires: a call for new approaches.
Int Arch Allergy Immunol 2013;161:122-6.
41. Durham SR, Gould HJ, Thienes CP, Jacobson MR, Masuyama K, Rak S, et al.
Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy
chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immu-
nol 1997;27:2899-906.
42. Gevaert P, Nouri-Aria KT, Wu H, Harper CE, Takhar P, Fear DJ, et al. Local recep-
tor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps.
Allergy 2013;68:55-63.
43. Cameron L, Gounni AS, Frenkiel S, Lavigne F, Vercelli D, Hamid Q. S epsilon S
mu and S epsilon S gamma switch circles in human nasal mucosa following
ex vivo allergen challenge: evidence for direct as well as sequential class switch
recombination. J Immunol 2003;171:3816-22.
44. Ganzer U, Bachert C. Localization of IgE synthesis in immediate-type allergy
of the upper respiratory tract. ORL J Otorhinolaryngol Relat Spec 1988;50:
257-64.
45. Kashiwakura J, Okayama Y, Furue M, Kabashima K, Shimada S, Ra C, et al. Most
highly cytokinergic IgEs have polyreactivity to autoantigens. Allergy Asthma Im-
munol Res 2012;4:332-40.
